Shin Nippon Biomedical Laboratories, Ltd.

Insider Reports History

Entity
Company
Location
2438 Miyanoura Machi, Kagoshima City, Kagoshima, Japan
Signature
Shin Nippon Biomedical Laboratories, Ltd., By: /s/ Shinji Nitanda, Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shin Nippon Biomedical Laboratories, Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Satsuma Pharmaceuticals, Inc. 10%+ Owner Common Stock 8.42M $7.67M $0.91 Jun 8, 2023 Indirect
Satsuma Pharmaceuticals, Inc. 10%+ Owner Common Stock 2.56M $2.33M $0.91 Jun 6, 2023 Direct

Insider Reports Filed by Shin Nippon Biomedical Laboratories, Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STSA Satsuma Pharmaceuticals, Inc. Jun 6, 2023 2 $27.7M 4 Jun 8, 2023 10%+ Owner